Physician profile
James S Garner
NPI 1215900675
$4,043.41
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $1,127 · 2021: $1,426 · 2022: $440.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $528.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $436.65 | 2019-2022 | |
| Novo Nordisk INC | $267.41 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $266.80 | 2019-2021 | |
| Allergan, INC. | $262.94 | 2019-2020 | |
| Amarin Pharma, INC. | $230.42 | 2019-2022 | |
| Pfizer INC. | $221.90 | 2019-2022 | |
| Astellas Pharma US INC | $217.31 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $195.95 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $190.35 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.59 | 2019-2022 | |
| Abbvie INC. | $172.17 | 2019-2022 | |
| Lilly USA, LLC | $141.35 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $102.59 | 2020-2021 | |
| Glaxosmithkline, LLC. | $82.00 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $76.22 | 2019-2022 | |
| Esperion Therapeutics, INC. | $75.97 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.01 | 2019-2021 | |
| Mylan Specialty L.P. | $62.42 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $62.15 | 2019-2020 | |
| Alkermes, INC. | $44.51 | 2019-2020 | |
| Medicure Pharma INC. | $38.87 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $32.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $25.07 | 2021 | |
| Abbott Laboratories | $16.42 | 2021 | |
| Hikma Pharmaceuticals USA | $15.93 | 2019 | |
| Xeris Pharmaceuticals, INC. | $15.78 | 2021 | |
| Eisai INC. | $12.94 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.